Prescribing trends of sodium-glucose cotransporter 2 inhibitors in patients with heart failure with preserved, mildly reduced and reduced ejection fraction

被引:1
|
作者
Hofer, Felix [1 ]
Hammer, Andreas [1 ]
Steinacher, Eva [1 ]
Baumer, Ulrike [1 ]
Kazem, Niema [1 ]
Koller, Lorenz [1 ]
Richter, Bernhard [1 ]
Hengstenberg, Christian [1 ]
Sulzgruber, Patrick [1 ]
Niessner, Alexander [1 ]
机构
[1] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Waehringer Guertel 18-20, A-1090 Vienna, Austria
关键词
D O I
10.1093/ehjcvp/pvad022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:505 / 506
页数:2
相关论文
共 50 条
  • [21] Comprehensive Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure With Reduced Ejection Fraction: A Literature Review
    Lopez-Usina, Almendra
    Mantilla-Cisneros, Camila
    Llerena-Velastegui, Jordan
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2024, 16 (10): : 449 - 464
  • [22] Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Ismayl, Mahmoud
    Abbasi, Muhannad Aboud
    Al-Abcha, Abdullah
    El-Am, Edward
    Lundgren, Scott
    Goldsweig, Andrew M.
    Anavekar, Nandan S.
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (05)
  • [23] A Meta-Analysis of the Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Heart Failure and Preserved Ejection Fraction
    Al-Abdouh, Ahmad
    Mhanna, Mohammed
    Barbarawi, Mahmoud
    Abusnina, Waiel
    Gupta, Vedant A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 164 : 138 - 141
  • [24] Egyptian expert opinion for the use of sodium-glucose cotransporter-2 inhibitors in patients with heart failure with reduced ejection fraction
    Abdelhamid, Magdy
    Kandil, Hossam
    Hassanin, Mahmoud
    Shaheen, Sameh
    Sobhy, Mohamed
    ElEtreby, Adel
    Hasan-Ali, Hosam
    Mahfouz, Hala
    Nasr, Gamila
    Shawky, Islam
    Emil, Sameh
    ElSetiha, Mohamed
    Hasssan, Mohamed
    Sadek, Yasser
    Karim, Mohamed Abdelghany
    Asham, Ayman
    Ghaleb, Mohamed
    Samir, Ahmad
    Shokry, Khaled
    ESC HEART FAILURE, 2022, 9 (02): : 800 - 811
  • [25] Impact of in-hospital initiation of sodium-glucose cotransporter-2 inhibitors in patients with heart failure and reduced ejection fraction
    Burgos, L.
    Ballari, F.
    Spaccavento, A.
    Ricciardi, B.
    Suarez, L.
    Vila, R. Baro
    Campos Cevera, L.
    Chicote, F.
    Fasan, M.
    Fescina, J.
    Arias, R.
    Santos Gallego, C.
    Diez, M.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [26] Efficacy of sodium glucose cotransporter-2 inhibitors for heart failure with preserved and with mildly reduced ejection fraction: a systematic review and meta-analysis
    Cordovez, R. A. B. Rey Adam
    Denila, R. W.
    Rivera, K. A.
    Patricio, M. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 114 - 114
  • [27] Sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction: Treat the heart, cherish the kidney
    Voordes, Geert
    Damman, Kevin
    EUROPEAN JOURNAL OF HEART FAILURE, 2023,
  • [28] RENAL EFFECTS OF SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS IN PATIENTS WITH HEART FAILURE WITH REDUCED OR PRESERVED EJECTION FRACTION
    Patoulias, Dimitrios
    Katsimardou, Alexandra
    Boulmpou, Aristi
    Siskos, Fotios
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Zografou, Ioanna
    Papadopoulos, Christodoulos
    Doumas, Michael
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL 1) : E70 - E70
  • [29] UNDERSTANDING BARRIERS AND FACILITATORS TO PRESCRIBING SODIUM-GLUCOSE TRASNPORTER-2 INHIBITORS IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION
    Pradhan, A.
    Lussier, M.
    Nguyen, M.
    Voyce, S.
    Wright, E.
    VALUE IN HEALTH, 2023, 26 (06) : S241 - S242
  • [30] Renal effects of sodium-glucose co-transporter-2 inhibitors in patients with heart failure with reduced or preserved ejection fraction
    Patoulias, Dimitrios
    Papadopoulos, Christodoulos
    Karagiannis, Asterios
    Doumas, Michael
    NEFROLOGIA, 2024, 44 (04): : 584 - 585